Bausch Health Companies Inc. BHC Cash Flow

Bausch health companies inc. (BHC)

CashFlow / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'09	Jun'09
Cash Flows From Operating Activities
Cash Flows From Operating Activities
Net loss
-152,000	-1,517,000	-48,000	-170,000	-48,000	-342,000	-351,000	-872,000	-2,579,000	512,000	1,300,000	-37,000	629,000	-512,000	-1,219,000	-304,000	-373,000	-386,600	51,700	-51,600	98,500	501,900	276,400	122,000	-20,300	125,000	-971,900	10,800	-27,500	-89,117	7,645	-21,607	-12,921	55,855	40,862	56,360	6,482	40,362	24,090
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization of intangible assets
481,000	492,000	520,000	531,000	532,000	546,000	703,000	784,000	786,000	819,000	698,000	667,000	674,000	707,000	708,000	720,000	731,000	698,600	726,400	635,000	407,000	365,900	439,300	407,700	401,100	410,500	946,000	317,900	341,400	313,441	235,311	221,866	215,582	208,389	154,936	122,276	127,002	43,293	32,089
Amortization and write-off of debt premiums, discounts and issuance costs
15,000	14,000	17,000	15,000	17,000	17,000	18,000	21,000	23,000	51,000	34,000	23,000	43,000	29,000	32,000	36,000	21,000	21,300	20,500	92,700	10,500	11,900	34,600	11,300	12,200	19,000	27,600	33,300	9,600	22,065	8,979	-391	5,747	7,229	12,685	2,414	4,775	5,300	5,301
Asset Impairment Charges
14,000	26,000	33,000	13,000	3,000	134,000	89,000	301,000	44,000	85,000	406,000	85,000	138,000	28,000	148,000	230,000	16,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	385	9,674
Goodwill, Impairment Loss
-	-	-	-	-	109,000	0	0	2,213,000	0	312,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discounts on long-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,642	2,682	564
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,292	1,228	968
In-process research and development impairments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	95,800	12,300	-	-	19,900	400	-	-	124,000	4,800	-	-	145,300	4,568	-	105,200	0	2,000	2,000	8,126	30,414
Acquisition accounting adjustment on inventory sold
-	-	-	-	-	-	-	-	-	-	-	-	-	0	2,000	7,000	29,000	36,300	27,200	46,000	24,500	5,100	12,400	4,300	5,200	153,200	149,400	26,600	43,200	29,399	6,009	10,294	33,098	10,650	2,768	16,262	29,576	-	-
Acquisition-related contingent consideration
13,000	10,000	3,000	20,000	-21,000	14,000	-19,000	-6,000	2,000	8,000	-238,000	-49,000	-10,000	-31,000	9,000	7,000	2,000	-45,600	3,800	11,700	7,100	-28,800	4,000	1,900	8,900	4,300	-35,000	3,700	-2,200	-28,498	5,630	7,729	9,839	-20,028	6,904	1,752	386	-	-
Allowances for losses on trade receivable and inventories
15,000	29,000	19,000	14,000	13,000	21,000	15,000	16,000	17,000	48,000	23,000	24,000	24,000	78,000	44,000	24,000	28,000	68,600	19,600	14,600	12,200	33,400	12,000	16,000	19,600	31,600	16,100	11,600	9,000	8,864	6,833	1,720	4,383	1,307	1,740	2,091	381	-	-
Deferred income taxes
-70,000	3,000	-92,000	-25,000	-116,000	-142,000	40,000	110,000	-152,000	-1,401,000	-1,778,000	-253,000	-954,000	74,000	-145,000	-139,000	-26,000	-84,500	-91,400	-50,100	66,000	-59,200	74,600	-21,400	10,000	-229,700	-185,600	-63,200	-37,400	-191,798	-107,093	-5,850	-14,859	-145,861	-38,601	-18,724	-19,773	3,800	400
Gain (Loss) on Disposition of Assets
1,000	-	1,000	-1,000	10,000	-	-26,000	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
(Gain) loss on disposal of assets and businesses
-	-	-	-	-	-	-	-	-	-116,000	328,000	50,000	317,000	-3,000	0	13,000	-2,000	-	-5,300	-	-	-	254,500	-	-	-	-600	-	-	-20	-229	-1,024	-9,527	0	0	0	5,314	-	-
Gain (Loss) Related to Litigation Settlement
-23,000	-1,389,000	-9,000	-1,000	-2,000	-3,000	40,000	1,000	-11,000	-114,000	-3,000	-33,000	-76,000	-91,000	-1,000	35,000	-2,000	-5,100	-25,600	-4,800	-1,500	-3,200	900	-1,500	48,800	-65,300	-149,600	-1,100	-4,500	-21	0	-53,624	-3,155	-9,441	0	-2,000	-400	-	-
Payments of accrued legal settlements
3,000	11,000	3,000	0	1,000	2,000	2,000	50,000	170,000	0	8,000	213,000	0	1,000	17,000	48,000	3,000	900	26,200	2,900	3,000	1,900	200	900	0	-	200	11,700	-	2,249	37,739	1,752	60	10,141	0	400	16,000	24,648	-
Loss on deconsolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-18,000	-	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
27,000	25,000	26,000	27,000	24,000	22,000	22,000	22,000	21,000	17,000	19,000	23,000	28,000	31,000	37,000	33,000	64,000	28,600	50,500	25,900	35,000	17,400	20,200	15,600	24,800	13,000	16,000	7,400	9,100	13,345	18,547	15,156	19,152	20,985	17,587	25,558	29,893	1,126	1,334
Tax expense (benefit) from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,700	17,900	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Excess tax expense (benefits) from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,900	7,700	-	-	15,900	0	1,200	-	32,200	11,800	4,600	-	2,367	2,882	593	-	2,042	7,566	24,050	-	-
Foreign exchange loss
-16,000	1,000	-10,000	2,000	0	3,000	1,000	-10,000	25,000	23,000	13,000	39,000	31,000	-29,000	-1,000	14,000	2,000	1,600	-31,000	10,300	-75,900	-72,600	-55,100	5,300	-12,600	-6,400	5,400	-10,600	1,800	1,891	-356	-3,299	25,564	4,167	-3,611	1,100	3,173	-	-
Interest expense on cross-currency swaps
6,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-35	2,059	-	-	21,316	-	-	-
Gain (Loss) on Extinguishment of Debt
-24,000	-2,000	0	-33,000	-7,000	-44,000	0	-48,000	-27,000	-57,000	-1,000	0	-64,000	0	0	0	0	0	0	0	-20,000	-36,300	0	0	-93,700	-35,400	-8,200	0	-21,400	-17,645	-2,322	0	-133	-	-	-	8,262	-	-
Payments of contingent consideration adjustments, including accretion
-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	19,000	6,000	2,000	-	7,700	9,900	2,200	-20,500	1,300	7,500	700	4,900	3,300	2,300	600	-	552	898	-	-	-	-	-	-	-
Payment of accreted interest on repurchase of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,289	-	-
Gain on disposal of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	466	344
Other
7,000	-9,000	-11,000	-7,000	-9,000	-2,000	17,000	-1,000	3,000	-2,000	22,000	0	2,000	-38,000	3,000	8,000	1,000	23,300	-200	2,700	7,200	-16,300	-9,700	3,700	-9,700	-12,500	4,900	7,700	3,700	-1,940	7,867	60	7,613	26,096	9,170	-12,623	-4,225	-89	192
Changes in operating assets and liabilities:
Trade receivables
-69,000	71,000	-54,000	33,000	-89,000	-160,000	72,000	76,000	-204,000	-79,000	114,000	-20,000	-432,000	3,000	-12,000	49,000	-6,000	-30,000	347,200	241,800	67,000	366,800	121,400	53,700	30,100	194,400	-54,800	49,300	111,700	-13,449	182,646	-8,183	14,786	70,749	43,087	-31,736	82,481	1,938	14,204
Inventories
94,000	4,000	84,000	53,000	68,000	-3,000	-4,000	12,000	0	-6,000	-1,000	-38,000	38,000	-2,000	21,000	59,000	86,000	91,100	45,600	48,300	91,000	70,200	41,500	12,100	69,200	17,600	46,200	34,000	24,900	19,000	9,787	16,433	35,080	11,453	5,211	8,217	-13,360	2,392	9,960
Prepaid expenses and other current assets
18,000	15,000	-15,000	-16,000	15,000	19,000	-23,000	6,000	70,000	-1,000	-12,000	-18,000	-2,000	-114,000	44,000	-5,000	-157,000	-161,000	88,500	118,400	45,100	144,500	-5,500	-24,800	-4,200	-41,300	-48,000	-9,900	-22,300	-20,657	6,324	-1,133	4,266	898	7,813	-12,497	6,870	6,085	-2,770
Accounts payable, accrued and other liabilities
-85,000	-116,000	26,000	-55,000	-4,000	-228,000	84,000	-66,000	89,000	88,000	143,000	-40,000	196,000	-174,000	-5,000	61,000	-26,000	-34,100	281,600	111,200	-33,700	299,600	90,700	-124,900	52,600	-79,200	-53,900	47,400	9,200	-52,700	84,041	-24,156	-15,585	-	37,618	-25,860	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-37,806	6,773	6,223
Accrued liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	62,742	18,681	20,512
Income taxes payable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	920	-13,730	-863	886	-320
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,081	2,773	-2,020
Net cash provided by operating activities
261,000	234,000	515,000	339,000	413,000	319,000	522,000	222,000	438,000	578,000	490,000	268,000	954,000	512,000	570,000	448,000	557,000	618,900	736,500	410,500	491,100	833,000	618,700	376,000	484,300	279,900	201,700	305,100	255,300	67,941	166,827	254,602	167,230	189,780	173,707	190,656	86,330	89,197	97,081
Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired
0	0	0	0	180,000	0	0	0	-5,000	0	0	0	0	0	0	0	19,000	1,456,300	115,800	13,090,900	795,000	120,900	606,800	68,000	306,300	63,100	4,439,400	513,400	237,600	2,513,101	245,367	454,020	272,812	1,494,785	409,056	96,565	463,702	-	200,000
Acquisition of intangible assets and other assets
-	-	-	-	-	2,000	1,000	61,000	14,000	19,000	5,000	10,000	131,000	8,000	38,000	3,000	7,000	9,900	100	9,200	48,800	73,200	74,300	10,400	21,100	31,500	4,900	32,500	700	64,635	6,305	695	1,865	4,315	12,237	8,000	302,885	8,126	540,889
Purchases of property, plant and equipment
72,000	78,000	83,000	62,000	47,000	62,000	32,000	30,000	33,000	53,000	43,000	37,000	38,000	54,000	53,000	66,000	62,000	71,300	51,100	46,800	65,800	80,800	39,600	113,500	58,100	63,600	24,900	12,800	14,000	25,814	57,069	13,601	11,116	14,952	9,584	12,474	21,505	1,083	842
Settlement of foreign currency forward exchange contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	26,300	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of marketable securities
2,000	8,000	3,000	3,000	2,000	2,000	1,000	4,000	0	-	-	-	-	-	-	-	-	-	24,200	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	16,800	32,500	0	17,700	53,000	0	0	0	18,200	0	8,000	9,000	615,388	0	1,048	8,364	0	0	83,865	2,774	13	1,065
Purchase of equity method investment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	75,900	-	-	0	0	-	-7,200	0	0	7,200	0	11,745	29,326	40,016	-	-
Proceeds from sale of marketable securities
2,000	7,000	2,000	0	1,000	2,000	1,000	2,000	2,000	0	1,000	1,000	0	0	2,000	9,000	6,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest settlements from cross-currency swaps
11,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sale of assets and businesses, net of costs to sell
21,000	1,000	11,000	8,000	25,000	2,000	38,000	2,000	-8,000	190,000	919,000	827,000	1,317,000	68,000	20,000	111,000	0	10,500	2,500	0	0	-	1,477,000	-	-	13,700	0	19,000	8,400	15,033	10,717	0	66,250	-	-	36,000	-	5,189	-
Reduction of cash due to deconsolidation
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	30,000	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net settlement of assumed derivative contracts
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	184,600	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	25,800	0	-10,343,900	10,349,100	0	0	0	0	-	-	-	-	-	-628	8,873	-	-	-	-	-	-	-
Proceeds from sale and leaseback of assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,300
Additions to marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,060	1,744
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	500	-500	-	-	-1,400	-1,400	-	-	-	-	-	-	-	-	-	-	-	-	-553	-357
Net cash used in investing activities
-40,000	-85,000	-73,000	-58,000	-203,000	-62,000	5,000	-91,000	-48,000	90,000	869,000	780,000	1,148,000	6,000	-69,000	50,000	-112,000	-1,535,100	-156,200	-2,645,200	-11,240,500	-205,800	756,300	-266,400	-384,100	-144,500	-4,469,200	-531,700	-234,900	-1,973,784	-297,396	-476,141	-218,379	-1,514,052	-442,622	-26,500	-825,334	-4,514	-736,753
Cash Flows From Financing Activities
Cash Flows From Financing Activities
Issuance of long-term debt, net of discounts
-3,000	2,722,000	-5,000	1,729,000	1,514,000	1,473,000	-3,000	5,993,000	1,481,000	3,193,000	-1,000	-2,000	6,234,000	0	0	0	1,220,000	894,600	0	4,921,400	12,001,000	665,100	555,000	49,300	360,600	880,300	7,165,100	340,000	0	4,597,095	122,295	640,767	645,643	2,459,111	690,000	100,000	2,139,688	-	-
Repayments of Long-term Debt
1,459,000	450,000	453,000	1,882,000	1,621,000	1,901,000	364,000	6,105,000	1,731,000	4,954,000	1,410,000	220,000	7,619,000	519,000	644,000	847,000	426,000	667,800	29,000	247,900	1,110,300	1,704,000	1,629,800	120,300	433,900	940,400	4,781,100	174,700	430,000	1,468,044	31,063	127,181	302,812	1,018,553	11,088	0	975,000	-	-
Borrowings of short-term debt
-	-	-	-	-	-	-	-	-	-	-	-	-	0	1,000	1,000	1,000	1,100	1,000	2,700	3,200	-	-	-	-	4,000	4,800	14,100	4,500	6,870	8,930	12,236	7,364	-	-	-	-	-	-
Repayments of short-term debt
-	-	-	-	-	2,000	0	0	1,000	0	1,000	6,000	1,000	0	1,000	1,000	1,000	-3,117,100	0	3,122,800	2,300	-	0	0	-	37,600	25,200	10,900	1,400	-	4,820	21,582	-	-	-	-	-	-	-
Repayments of convertible notes assumed
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	3,975	71,871	202,587	199,788	139,225	-	-
Cash dividends paid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,240	59,331
Issuance of common stock, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-700	0	0	1,433,700	0	0	0	0	-	-1,300	2,271,200	-	-	0	0	-	-	-	-	-	-	-
Repurchases of common shares
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	50,000	-	-	0	0	-	0	0	20,600	35,000	-24	0	172,000	108,724	65,122	74,556	224,814	274,750	-	-
Settlement of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of stock options
-	-	-	-	-	-	-	-	-	-	-	-	-	0	32,000	0	1,000	900	7,000	7,600	14,500	6,100	3,800	3,600	3,500	2,900	2,500	2,000	2,600	10,772	5,209	1,911	5,108	7,529	4,847	6,133	23,229	26	18
Tax (expense) benefit from share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,000	-	-3,900	7,700	17,900	-	15,900	0	1,200	-24,400	32,200	11,800	4,600	6,658	2,367	2,882	593	-7,125	2,042	7,566	24,050	-	-
Cash settlement of convertible debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	62,086	-	-	-	-	-	-	-	-
Cash settlement of call options
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	66,864	-	-	-	-
Payments of employee withholding taxes related to share-based awards
24,000	0	1,000	5,000	34,000	0	2,000	3,000	5,000	0	1,000	3,000	0	2,000	2,000	-1,000	8,000	2,200	24,300	45,600	15,900	5,500	2,000	8,800	27,700	29,600	14,400	14,700	6,800	9,990	7,376	9,910	3,824	2,563	2,477	15,200	39,478	-	-
Payments of acquisition-related contingent consideration
17,000	-	-	-	9,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of acquisition-related contingent consideration
-	-	-	-	-	-	8,000	7,000	11,000	-	9,000	17,000	8,000	29,000	50,000	18,000	26,000	21,600	48,400	68,700	12,300	9,400	14,400	72,500	9,700	32,000	15,200	61,800	21,100	24,056	18,826	33,518	27,500	-	-	-	-	-	-
Payments of deferred consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	23,000	1,000	16,000	500,000	55,000	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of noncontrolling interest
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of financing costs
18,000	2,000	0	25,000	1,000	40,000	3,000	39,000	20,000	71,000	0	1,000	38,000	1,000	31,000	65,000	0	4,700	0	75,100	23,200	31,700	10,200	200	9,900	-8,400	46,900	300	33,300	8,096	22,562	1,107	1,435	9,081	11,777	4,066	15,747	-	26,274
Other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	0	-	-	-	28,515	-	-	-	-
Issuance of 5.375% Convertible Notes
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	350,000
Advances under credit facilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	130,000
Repayments under credit facilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	75,000	-
Other
0	-7,000	-4,000	2,000	1,000	-21,000	-6,000	2,000	-1,000	0	-8,000	0	-10,000	-1,000	-1,000	-8,000	1,000	-	-9,900	-1,300	0	-	-400	-7,700	-6,800	-	-2,100	0	-	-	-	-	-	-	-	-	-	-	-393
Net cash used in financing activities
-1,521,000	2,255,000	-474,000	-188,000	-150,000	-502,000	-386,000	-177,000	-288,000	-1,842,000	-1,430,000	-249,000	-1,442,000	-575,000	-697,000	-951,000	260,000	100,900	-108,500	1,325,300	12,306,300	-1,098,600	-1,082,100	-156,600	-122,700	-130,900	2,318,400	2,356,100	-515,900	2,562,296	-7,932	292,498	210,438	1,236,542	299,025	-330,169	742,767	-89,214	394,020
Effect of exchange rate changes on cash and cash equivalents
-21,000	13,000	-21,000	3,000	1,000	-5,000	-6,000	-25,000	10,000	2,000	15,000	16,000	8,000	-60,000	3,000	-5,000	8,000	-8,100	-9,800	3,000	-15,100	-14,100	-15,300	1,900	-1,500	-500	6,000	-3,800	-6,900	1,928	965	-6,172	7,079	-2,718	-14,496	3,206	3,720	1,019	876
Net (decrease) increase in cash and cash equivalents and restricted cash
-1,321,000	2,417,000	-53,000	96,000	61,000	-250,000	135,000	-71,000	112,000	-1,172,000	-56,000	815,000	668,000	-117,000	-193,000	-458,000	713,000	-823,400	462,000	-906,400	1,541,800	-	277,600	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-3,512	-244,776
Net (decrease) increase in cash and cash equivalents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-906,400	-	-	-	-45,100	-24,000	4,000	-1,943,100	2,125,700	-502,400	658,381	-137,536	64,787	166,368	-90,448	15,614	-162,807	7,483	-	-
Non-Cash Investing and Financing Activities
Acquisition of businesses, contingent and deferred consideration obligations at fair value (Restated)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108,700	387,700	286,900	-	16,000	27,400	21,700	8,700	0	8,300	59,100	37,903	17,257	108,284	-17,744	840,631	-55,056	-369,679	27,585	-	-
Settlement of convertible debt, equity issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-892,000	-	-	-
Acquisition of businesses, debt assumed
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	6,100	3,123,100	-	-	4,500	0	4,000	0	4,222,100	5,000	37,600	-	0	46,336	-	-	-	-	-	-	-
Additions to marketable securities, accrued but unpaid
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	20,008	-	-
Out-license of intangible asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	36,000	-	-